Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (FRA:08HH)

FRA:08HH Revenue

Shanghai Fosun Pharmaceutical (Group) had revenue of 9.88B CNY in the quarter ending September 30, 2025, a decrease of -5.46%. This brings the company's revenue in the last twelve months to 39.55B, down -4.96% year-over-year. In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B, down -0.80%.

• Revenue (ttm): 39.55B CNY
• Revenue Growth: -4.96%
• P/S Ratio: 1.74
• Revenue / Employee: 975.14K CNY
• Employees: 40,557
• Market Cap: 8.25B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	41.07B	-332.34M	-0.80%
Dec 31, 2023	41.40B	-2.55B	-5.81%
Dec 31, 2022	43.95B	4.94B	12.66%
Dec 31, 2021	39.01B	8.70B	28.72%
Dec 31, 2020	30.31B	1.72B	6.02%